Cancer

A novel class of drugs that target “BET” proteins may have broad utility for treating genetically diverse brain tumors. Read More

Vaccinating young males and females against several types of human papillomavirus (HPV) could dramatically reduce the incidence of HPV-related cancers worldwide, according to Douglas Lowy, M.D., deputy director of the National Cancer Institute. Read More

Vanderbilt researchers report that they have found a factor involved in the persistence of embryonic cells implicated in childhood liver cancer. Read More

Cancer patients undergoing some forms of chemotherapy often lose some or all of their hair, as well as eyebrows and eyelashes. Read More

What if you could prevent even one family member from hearing the words, “You have cancer”? The American Cancer Society is seeking volunteers from the Vanderbilt community to become “champions” who spread the word about a historic cancer research study coming to Langford Auditorium April 25. Many… Read More

The protein TIP-1 appears to be a novel prognostic marker for glioblastoma and may be a good therapeutic target for disrupting tumor-driven blood vessel development. Read More

Nearly every week since 1988, cancer patients and families visiting Vanderbilt University Medical Center have been able to count on a comforting routine — at least one morning per week they are greeted by the same smiling volunteer who dispenses a dose of friendship along with coffee, snacks and advice about how to navigate the sprawling Medical Center campus. Read More

Vanderbilt and University of California investigators have discovered the “cell of origin” for pancreatic ductal adenocarcinoma, a finding that could lead to early detection methods and new treatments. Read More

Cancer death rates for most forms of cancer have continued to decline in the United States among men and women and all major racial and ethnic groups, according to the latest Annual Report to the Nation on the Status of Cancer. Read More

Combining another drug with platinum-based chemotherapies may be more effective against ovarian cancer. Read More

Archived tissue samples are yielding new disease biomarkers. Read More

Eric Delpire, Ph.D., professor of Anesthesiology, Molecular Physiology and Biophysics and director of the Anesthesiology Basic Science Research Division, has spent the past 15 years developing genetically altered mice for use in scientific research, and he now knows the value of his research in a very personal way. Read More

The machinery that builds the characteristic shape of epithelial cells suppresses breast cancer formation and metastasis in a mouse model. Read More

Researchers have determined how a DNA lesion caused by exposure to chemicals may spark cancer formation. Read More

Patrick Grohar came to Vanderbilt in January from the National Cancer Institute, bringing with him his passions and self-motivation for lab-based work. His research focuses on drug discovery in pediatric sarcomas, cancers that develop in bone and soft tissues. Read More

Disney television personality Coco Jones will be the featured performer at this year’s Dunkin’ Donuts/Baskin-Robbins Family Day in Nashville. The annual T.J. Martell Foundation event, which raises funds in support of cancer research at institutions like Vanderbilt-Ingram Cancer Center, will be held Sunday, Nov. 11, from 1 to 4 p.m. at the Curb Event Center, Belmont University. Read More

Green tea may lower risk of some digestive cancers. Read More

Executives with Baptist Memorial Health Care Corporation in Memphis, Tenn., and Vanderbilt University Medical Center today announced an academic affiliation agreement — paving the way for new clinical research and academic education opportunities that are designed to enhance cancer programs. The new affiliation establishes a framework… Read More

New space on the 10th floor of the Critical Care Tower is allowing the myelosuppression unit to increase its number of available beds. (Photo by Susan Urmy) The 10th floor of Vanderbilt University Medical Center’s Critical Care Tower, housing a new myelosuppression unit, will open Oct. 27. Read More

Vanderbilt investigators have identified how two key components of cancer's invasive "switch" — the series of signaling events that turn on a tumor cell’s invasive behavior — work together. Read More